TD Cowen on Amylyx Pharmaceuticals inc. (AMLX): 'continue to see AMLX as undervalued for the potential of avexitide alone'
Go back to TD Cowen on Amylyx Pharmaceuticals inc. (AMLX): 'continue to see AMLX as undervalued for the potential of avexitide alone'| (NASDAQ: AMLX) | Delayed: 21.63 -0.85 (3.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.48 | 52 Week High | $ | |||
| Open | $22.35 | 52 Week Low | $ | |||
| Day High | $22.39 | P/E | N/A | |||
| Day Low | $21.29 | EPS | $ | |||
| Volume | 1,588,782 | |||||

